Cargando…
Onset of fulminant type 1 diabetes mellitus under immunotolerance status after long‐term therapy for chronic inflammatory demyelinating polyneuropathy
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2018
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215944/ https://www.ncbi.nlm.nih.gov/pubmed/29905029 http://dx.doi.org/10.1111/jdi.12796 |
| _version_ | 1783368241453727744 |
|---|---|
| author | Shigemoto, Ryo Anno, Takatoshi Ohnuki, Eiichi Kosaka, Satoru Okimoto, Niro Kaku, Kohei Kaneto, Hideaki |
| author_facet | Shigemoto, Ryo Anno, Takatoshi Ohnuki, Eiichi Kosaka, Satoru Okimoto, Niro Kaku, Kohei Kaneto, Hideaki |
| author_sort | Shigemoto, Ryo |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-6215944 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2018 |
| publisher | John Wiley and Sons Inc. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-62159442018-11-08 Onset of fulminant type 1 diabetes mellitus under immunotolerance status after long‐term therapy for chronic inflammatory demyelinating polyneuropathy Shigemoto, Ryo Anno, Takatoshi Ohnuki, Eiichi Kosaka, Satoru Okimoto, Niro Kaku, Kohei Kaneto, Hideaki J Diabetes Investig Letters to the Editor John Wiley and Sons Inc. 2018-06-15 2018-11 /pmc/articles/PMC6215944/ /pubmed/29905029 http://dx.doi.org/10.1111/jdi.12796 Text en © 2018 The Authors. Journal of Diabetes Investigation published by Asian Association for the Study of Diabetes (AASD) and John Wiley & Sons Australia, Ltd This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
| spellingShingle | Letters to the Editor Shigemoto, Ryo Anno, Takatoshi Ohnuki, Eiichi Kosaka, Satoru Okimoto, Niro Kaku, Kohei Kaneto, Hideaki Onset of fulminant type 1 diabetes mellitus under immunotolerance status after long‐term therapy for chronic inflammatory demyelinating polyneuropathy |
| title | Onset of fulminant type 1 diabetes mellitus under immunotolerance status after long‐term therapy for chronic inflammatory demyelinating polyneuropathy |
| title_full | Onset of fulminant type 1 diabetes mellitus under immunotolerance status after long‐term therapy for chronic inflammatory demyelinating polyneuropathy |
| title_fullStr | Onset of fulminant type 1 diabetes mellitus under immunotolerance status after long‐term therapy for chronic inflammatory demyelinating polyneuropathy |
| title_full_unstemmed | Onset of fulminant type 1 diabetes mellitus under immunotolerance status after long‐term therapy for chronic inflammatory demyelinating polyneuropathy |
| title_short | Onset of fulminant type 1 diabetes mellitus under immunotolerance status after long‐term therapy for chronic inflammatory demyelinating polyneuropathy |
| title_sort | onset of fulminant type 1 diabetes mellitus under immunotolerance status after long‐term therapy for chronic inflammatory demyelinating polyneuropathy |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215944/ https://www.ncbi.nlm.nih.gov/pubmed/29905029 http://dx.doi.org/10.1111/jdi.12796 |
| work_keys_str_mv | AT shigemotoryo onsetoffulminanttype1diabetesmellitusunderimmunotolerancestatusafterlongtermtherapyforchronicinflammatorydemyelinatingpolyneuropathy AT annotakatoshi onsetoffulminanttype1diabetesmellitusunderimmunotolerancestatusafterlongtermtherapyforchronicinflammatorydemyelinatingpolyneuropathy AT ohnukieiichi onsetoffulminanttype1diabetesmellitusunderimmunotolerancestatusafterlongtermtherapyforchronicinflammatorydemyelinatingpolyneuropathy AT kosakasatoru onsetoffulminanttype1diabetesmellitusunderimmunotolerancestatusafterlongtermtherapyforchronicinflammatorydemyelinatingpolyneuropathy AT okimotoniro onsetoffulminanttype1diabetesmellitusunderimmunotolerancestatusafterlongtermtherapyforchronicinflammatorydemyelinatingpolyneuropathy AT kakukohei onsetoffulminanttype1diabetesmellitusunderimmunotolerancestatusafterlongtermtherapyforchronicinflammatorydemyelinatingpolyneuropathy AT kanetohideaki onsetoffulminanttype1diabetesmellitusunderimmunotolerancestatusafterlongtermtherapyforchronicinflammatorydemyelinatingpolyneuropathy |